Source: Eur Respir J 2012; 39: 215-217



Rating:

Share or cite this content

Citations should be made in the following way:
Almendros I., Montserrat J.M., Ramírez J., Torres M., Duran-Cantolla J., Navajas D., Farré R.. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J 2012; 39: 215-217

Member's Comments

No comment yet.

Related content which might interest you: Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer Year: 2012 Chronic intermittent hypoxia mimicking sleep apnoea increases spontaneous tumorigenesis in mice Source: Eur Respir J , 49 (2) 1602111; DOI: 10.1183/13993003.02111-2016 Year: 2017 Chronic intermittent hypoxia reduces progressive sperm motility in a mouse model of obstructive sleep apnea Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Intermittent hypoxia in sleep apnea: a cause of inflammatory activation Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Intermittent hypoxia, the hallmark of sleep apnea, induces HIF-1-dependent mitochondrial dysfunction Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Late Breaking Abstract - Differential effect of intermittent hypoxia and sleep fragmentation in the progression of Alzheimer Disease in a mouse model of obstructive sleep apnea Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea Source: Eur Respir J, 51 (3) 1701885; 10.1183/13993003.01885-2017 Year: 2018 Aged mice obstructive sleep apnoea model with spontaneous tumorigenesis: physiological parameters Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Is sleep related to cancer in murine models of obstructive sleep disorder? Source: Eur Respir J 2012; 39: 1051 Year: 2012 Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea Source: Eur Respir J 2015; 45: 1055-1065 Year: 2015 Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Relationship between sleep apnoea and cancer Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 Sleep disordered breathing and nocturnal hypoxemia are associated with an increased risk of lung cancer. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Obstructive sleep apnoea: the effect of intermittent hypoxia on cognitive function Source: ERS Conference Year: 2015 The role of angiogenesis in obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 LATE-BREAKING ABSTRACT: Effects of long term intermittent hypoxia (IH) mimicking obstructive sleep apnea (OSA) on spontaneous tumorigenesis in aged mice Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing Year: 2015 Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients Source: Eur Respir J 2002; 20: 724-732 Year: 2002